Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.
This article is from
The Cancer Letter
archive.
Vol. 31 No. 19 | May 13, 2005
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Final Issue Of the Year
December 14, 1990
TCL Archive
Study Identifies Risk Factors To Predict Contralateral Cancer
February 27, 2009
TCL Archive
Schmidt’s Doubts Threaten Control Saturation Program
August 22, 1975
TCL Archive
First “Annual” CCOP RFA Issued; Research Bases Must Compete
June 8, 1990
TCL Archive
Federal Science: NASA, NCI Explore Research On Sensor Technologies
August 13, 1999
TCL Archive
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
February 26, 2010